Abstract
Functional genomics applied to the study of RNA expression profiles identified several abnormal molecular processes in experimental prion disease. However, only a few similar studies have been carried out to date in a naturally occurring human prion disease. To better characterize the transcriptional cascades associated with sporadic Creutzfeldt-Jakob disease (sCJD), the most common human prion disease, we investigated the global gene expression profile in samples from the frontal cortex of 10 patients with sCJD and 10 non-neurological controls by microarray analysis. The comparison identified 333 highly differentially expressed genes (hDEGs) in sCJD. Functional enrichment Gene Ontology analysis revealed that hDEGs were mainly associated with synaptic transmission, including GABA (q value = 0.049) and glutamate (q value = 0.005) signaling, and the immune/inflammatory response. Furthermore, the analysis of cellular components performed on hDEGs showed a compromised regulation of vesicle-mediated transport with mainly up-regulated genes related to the endosome (q value = 0.01), lysosome (q value = 0.04), and extracellular exosome (q value < 0.01). A targeted analysis of the retromer core component VPS35 (vacuolar protein sorting-associated protein 35) showed a down-regulation of gene expression (p value= 0.006) and reduced brain protein levels (p value= 0.002). Taken together, these results confirm and expand previous microarray expression profile data in sCJD. Most significantly, they also demonstrate the involvement of the endosomal-lysosomal system. Since the latter is a common pathogenic pathway linking together diseases, such as Alzheimer’s and Parkinson’s, it might be the focus of future studies aimed to identify new therapeutic targets in neurodegenerative diseases.
Similar content being viewed by others
Availability of Data and Materials
Microarray data will be deposited in the GEO database. Other datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
References
Golde TE, Borchelt DR, Giasson BI, Lewis J (2013) Thinking laterally about neurodegenerative proteinopathies. J Clin Invest 123:1847–1855. https://doi.org/10.1172/JCI66029
Paulson HL (1999) Protein fate in neurodegenerative proteinopathies: Polyglutamine diseases join the (mis)fold. Am J Hum Genet 64:339–345. https://doi.org/10.1086/302269
Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P (2011) Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: Insights into phenotypic variability and disease pathogenesis. Acta Neuropathol 121:21–37. https://doi.org/10.1007/s00401-010-0760-4
Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T et al (2005) Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 64:1586–1591. https://doi.org/10.1212/01.WNL.0000160117.56690.B2
Brown P, Farrell M (2015) A practical approach to avoiding iatrogenic Creutzfeldt-Jakob disease (CJD) from invasive instruments. Infect Control Hosp Epidemiol 36:844–848. https://doi.org/10.1017/ice.2015.53
Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95:13363–13383
Basu U, Guan LL, Moore SS (2012) Functional genomics approach for identification of molecular processes underlying neurodegenerative disorders in prion diseases. Curr Genomics 13:369–378. https://doi.org/10.2174/138920212801619223
Hwang D, Lee IY, Yoo H, Gehlenborg N, Cho JH, Petritis B, Baxter D, Pitstick R et al (2009) A systems approach to prion disease. Mol Syst Biol 5:252. https://doi.org/10.1038/msb.2009.10
Barbisin M, Vanni S, Schmädicke AC, Montag J, Motzkus D, Opitz L, Salinas-Riester G, Legname G (2014) Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques. BMC Genomics 5:434. https://doi.org/10.1186/1471-2164-15-434
Xiang W, Windl O, Westner IM, Neumann M, Zerr I, Lederer RM, Kretzschmar HA (2005) Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease. Ann Neurol 58:242–257. https://doi.org/10.1002/ana.20551
Llorens F, Ansoleaga B, Garcia-Esparcia P, Zafar S, Grau-Rivera O, López-González I, Blanco R, Carmona M et al (2013) PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2. Prion 7:383–893. https://doi.org/10.4161/pri.26416
López González I, Garcia-Esparcia P, Llorens F, Ferrer I (2016) Genetic and transcriptomic profiles of inflammation in neurodegenerative diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and tauopathies. Int J Mol Sci 17:206. https://doi.org/10.3390/ijms17020206
Burns TC, Li MD, Mehta S, Awad AJ, Morgan AA (2015) Mouse models rarely mimic the transcriptome of human neurodegenerative diseases: A systematic bioinformatics-based critique of preclinical models. Eur J Pharmacol 759:101–117. https://doi.org/10.1016/j.ejphar.2015.03.02.
Durrenberger PF, Fernando S, Kashefi SN, Ferrer I, Hauw JJ, Seilhean D, Smith C, Walker R et al (2010) Effects of antemortem and postmortem variables on human brain mRNA quality: A BrainNet Europe study. J Neuropathol Exp Neurol 69:70–81. https://doi.org/10.1097/NEN.0b013e3181c7e32f
Twine NA, Janitz K, Wilkins MR, Janitz M (2011) Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer’s disease. PLoS One 6:e16266. https://doi.org/10.1371/journal.pone.0016266
Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P, Gelpi E, Giaccone G et al (2012) Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: An inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124:517–529. https://doi.org/10.1007/s00401-012-1002-8
Parchi P, Notari S, Weber P, Schimmel H, Budka H, Ferrer I, Haik S, Hauw JJ et al (2009) Inter-laboratory assessment of PrPSc typing in Creutzfeldt-Jakob disease: A Western blot study within the NeuroPrion Consortium. Brain Pathol 19:384–391. https://doi.org/10.1111/j.1750-3639.2008.00187.x
Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233
Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP et al (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: A practical approach. Acta Neuropathol 123:1–11. https://doi.org/10.1007/s00401-011-0910-3
Durrenberger PF, Fernando FS, Magliozzi R, Kashefi SN, Bonnert TP, Ferrer I, Seilhean D, Nait-Oumesmar B et al (2012) Selection of novel reference genes for use in the human central nervous system: A BrainNet Europe Study. Acta Neuropathol 124:893–903. https://doi.org/10.1007/s00401-012-1027-z
Bartoletti-Stella A, Gasparini L, Giacomini C, Corrado P, Terlizzi R, Giorgio E, Magini P, Seri M et al (2015) Messenger RNA processing is altered in autosomal dominant leukodystrophy. Hum Mol Genet 24:2746–2756. https://doi.org/10.1093/hmg/ddv034
Mlecnik B, Galon J, Bindea G (2018) Comprehensive functional analysis of large lists of genes and proteins. J Proteome 171:2–10. https://doi.org/10.1016/j.jprot.2017.03.016
Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D, Thomas PD (2017) PANTHER version 11: Expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res 45:D183–D189. https://doi.org/10.1093/nar/gkw1138.
Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57. https://doi.org/10.1038/nprot.2008.211
Davis MJ, Ragan MA (2013) Understanding cellular function and disease with comparative pathway analysis. Genome Med 5:64. https://doi.org/10.1186/gm468
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL et al (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550. https://doi.org/10.1073/pnas.0506580102
Shoemaker JE, Lopes TJS, Ghosh S, Matsuoka Y, Kawaoka Y, Kitano H et al (2012) CTen: A web-based platform for identifying enriched cell types from heterogeneous microarray data. BMC Genomics 13:460. https://doi.org/10.1186/1471-2164-13-460
Rydbirk R, Folke J, Winge K, Aznar S, Pakkenberg B, Brudek T (2016) Assessment of brain reference genes for RT-qPCR studies in neurodegenerative diseases. Sci Rep 6:37116. https://doi.org/10.1038/srep37116
Millier MJ, Stamp LK, Hessian PA (2017) Digital-PCR for gene expression: Impact from inherent tissue RNA degradation. Sci Rep 7:17235. https://doi.org/10.1038/s41598-017-17619-0
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262
Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100:9440–9445. https://doi.org/10.1073/pnas.1530509100
Babicki S, Arndt D, Marcu A, Liang Y, Grant JR, Maciejewski A, Wishart DS (2016) Heatmapper: Web-enabled heat mapping for all. Nucleic Acids Res 8(44):W147–W153. https://doi.org/10.1093/nar/gkw419.
Ramaker RC, Bowling KM, Lasseigne BN, Hagenauer MH, Hardigan AA, Davis NS, Gertz J, Cartagena PM et al (2017) Post-mortem molecular profiling of three psychiatric disorders. Genome Med 9:72. https://doi.org/10.1186/s13073-017-0458-5
Darmanis S, Sloan SA, Zhang Y, Enge M, Caneda C, Shuer LM, Hayden Gephart MG, Barres BA et al (2015) A survey of human brain transcriptome diversity at the single cell level. Proc Natl Acad Sci U S A 112:7285–7290. https://doi.org/10.1073/pnas.1507125112
Bouzamondo-Bernstein E, Hopkins SD, Spilman P, Uyehara-Lock J, Deering C, Safar J, Prusiner SB, Ralston HJ III et al (2004) The neurodegeneration sequence in prion diseases: Evidence from functional, morphological and ultrastructural studies of the GABAergic system. J Neuropathol Exp Neurol 63:882–899
Bombardier JP, Munson M (2015) Three steps forward, two steps back: Mechanistic insights into the assembly and disassembly of the SNARE complex. Curr Opin Chem Biol 29:66–71. https://doi.org/10.1016/j.cbpa.2015.10.003
Guentchev M, Groschup MH, Kordek R, Liberski PP, Budka H (1998) Severe, early and selective loss of a subpopulation of GABAergic inhibitory neurons in experimental transmissible spongiform encephalopathies. Brain Pathol 8:615–623
Trifilo MJ, Sanchez-Alavez M, Solforosi L, Bernard-Trifilo J, Kunz S, McGavern D, Oldstone MBA (2008) Scrapie-induced defects in learning and memory of transgenic mice expressing anchorless prion protein are associated with alterations in the gamma aminobutyric acid-ergic pathway. J Virol 82:9890–9899. https://doi.org/10.1128/JVI.00486-08
Aguzzi A, Zhu C (2017) Microglia in prion diseases. J Clin Invest 127:3230–3239. https://doi.org/10.1172/JCI90605
Gehlenborg N, Hwang D, Lee IY, Yoo H, Baxter D, Petritis B et al (2009) The Prion Disease Database: a comprehensive transcriptome resource for systems biology research in prion diseases. Database (Oxford) 2009:bap011. https://doi.org/10.1093/database/bap011
Uchiyama K, Muramatsu N, Yano M, Usui T, Miyata H, Sakaguchi S (2013) Prions disturb post-Golgi trafficking of membrane proteins. Nat Commun 4:1846. https://doi.org/10.1038/ncomms2873
Shim SY, Karri S, Law S, Schatzl HM, Gilch S (2016) Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells. Sci Rep 6:21658. https://doi.org/10.1038/srep21658
MacLeod DA, Rhinn H, Kuwahara T, Zolin A, Di Paolo G, McCabe BD, Marder KS, Honig LS et al (2013) RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 77:425–439. https://doi.org/10.1016/j.neuron.2012.11.033
Wen L, Tang FL, Hong Y, Luo SW, Wang CL, He W, Shen C, Jung JU et al (2011) VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology. J Cell Biol 195:765–779. https://doi.org/10.1083/jcb.201105109
Muhammad A, Flores I, Zhang H, Yu R, Staniszewski A, Planel E, Herman M, Ho L et al (2008) Retromer deficiency observed in Alzheimer’s disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation. Proc Natl Acad Sci U S A 105:7327–7332. https://doi.org/10.1073/pnas.0802545105
Small SA, Kent K, Pierce A, Leung C, Kang MS, Okada H, Honig L, Vonsattel JP et al (2005) Model-guided microarray implicates the retromer complex in Alzheimer’s disease. Ann Neurol 58:909–919
Goold R, McKinnon C, Rabbanian S, Collinge J, Schiavo G, Tabrizi SJ (2013) Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane. J Cell Sci 126:3552–3562. https://doi.org/10.1242/jcs.120477
Yim YI, Park BC, Yadavalli R, Zhao X, Eisenberg E, Greene LE (2015) The multivesicular body is the major internal site of prion conversion. J Cell Sci 128:1434–1443. https://doi.org/10.1242/jcs.165472
Zhao H, Wang C, Yao L, Lin Q, Xu X, Hu L, Li W (2017) Identification of aged bloodstains through mRNA profiling: Experiments results on selected markers of 30- and 50-year-old samples. Forensic Sci Int 272:e1–e6. https://doi.org/10.1016/j.forsciint.2017.01.006
Takada LT, Geschwind MD (2013) Prion diseases. Semin Neurol 33:348–856. https://doi.org/10.1055/s-0033-1359314
Small SA, Petsko GA (2015) Retromer in Alzheimer disease, Parkinson disease and other neurological disorders. Nat Rev Neurosci 16:126–132. https://doi.org/10.1038/nrn3896
Sharief MK, Green A, Dick JP, Gawler J, Thompson EJ (1999) Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease. Neurology 52:1289–1291
Stoeck K, Bodemer M, Zerr I (2006) Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. J Neuroimmunol 172:175–181. https://doi.org/10.1016/j.jneuroim.2005.10.008
Llorens F, López-González I, Thüne K, Carmona M, Zafar S, Andréoletti O et al (2014) Subtype and regional-specific neuroinflammation in sporadic Creutzfeldt-Jakob disease. Front Aging Neurosci 6:198. https://doi.org/10.3389/fnagi.2014.00198
Shi Q, Chen LN, Zhang BY, Xiao K, Zhou W, Chen C, Zhang XM, Tian C et al (2015) Proteomics analyses for the global proteins in the brain tissues of different human prion diseases. Mol Cell Proteomics 14:854–869. https://doi.org/10.1074/mcp.M114.038018
Booth S, Bowman C, Baumgartner R, Sorensen G, Robertson C, Coulthart M et al (2004) Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection. J Gen Virol 85:3459–3471
Xiang W, Hummel M, Mitteregger G, Pace C, Windl O, Mansmann U, Kretzschmar HA (2007) Transcriptome analysis reveals altered cholesterol metabolism during the neurodegeneration in mouse scrapie model. J Neurochem 102:834–847. https://doi.org/10.1111/j.1471-4159.2007.04566.x
Vanni S, Moda F, Zattoni M, Bistaffa E, De Cecco E, Rossi M et al (2017) Differential overexpression of SERPINA3 in human prion diseases. Sci Rep 7:15637. https://doi.org/10.1038/s41598-017-157788.
Heit C, Jackson BC, McAndrews M, Wright MW, Thompson DC, Silverman GA, Nebert DW, Vasiliou V (2013) Update of the human and mouse SERPIN gene superfamily. Hum Genomics 7:22. https://doi.org/10.1186/1479-7364-7-22
Cardone F, Pocchiari M (2001) A role for complement in transmissible spongiform encephalopathies. Nat Med 7:410–411. https://doi.org/10.1038/86469
Klein MA, Kaeser PS, Schwarz P, Weyd H, Xenarios I, Zinkernagel RM (2001) Complement facilitates early prion pathogenesis. Nat Med 7:488–492. https://doi.org/10.1038/86567
Mitchell DA, Kirby L, Paulin SM, Villiers CL, Sim RB (2007) Prion protein activates and fixes complement directly via the classical pathway: Implications for the mechanism of scrapie agent propagation in lymphoid tissue. Mol Immunol 44:2997–3004. https://doi.org/10.1016/j.molimm.2006.12.027
Kovacs GG, Gasque P, Ströbel T, Lindeck-Pozza E, Strohschneider M, Ironside JW, Budka H, Guentchev M (2004) Complement activation in human prion disease. Neurobiol Dis 15:21–28
Bonifati DM, Kishore U (2007) Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 44:999–1010
Mabbott NA, Bruce ME, Botto M, Walport MJ, Pepys MB (2001) Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med 7:485–487. https://doi.org/10.1038/86562
Anisman H, Gibb J, Hayley S (2008) Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: Corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology 199:231–244. https://doi.org/10.1007/s00213-008-1166-z
Frankola KA, Greig NH, Luo W, Tweedie D (2011) Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets 10:391–403. https://doi.org/10.2174/187152711794653751
Mallucci GR, Ratté S, Asante EA, Linehan J, Gowland I, Jefferys JG et al (2002) Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 21:202–210. https://doi.org/10.1093/emboj/21.3.202
Rangel A, Madroñal N, Gruart A, Gavín R, Llorens F, Sumoy L et al (2009) Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term potentiation in the hippocampus of prion mutant mice. PLoS One 4:e7592. https://doi.org/10.1371/journal.pone.0007592
Rincon-Limas DE, Casas-Tinto S, Fernandez-Funez P (2010) Exploring prion protein biology in flies: Genetics and beyond. Prion 4:1–8
Robinson SW, Nugent ML, Dinsdale D, Steinert JR (2014) Prion protein facilitates synaptic vesicle release by enhancing release probability. Hum Mol Genet 23:4581–4596. https://doi.org/10.1093/hmg/ddu17.
Ferrer I (2002) Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease. Cerebellum 1:213–222. https://doi.org/10.1080/14734220260418448
Senatore A, Restelli E, Chiesa R (2013) Synaptic dysfunction in prion diseases: A trafficking problem? Int J Cell Biol 2013:543803. https://doi.org/10.1155/2013/543803
Ferrer I, Puig B (2003) GluR2/3, NMDAepsilon1 and GABAA receptors in Creutzfeldt-Jakob disease. Acta Neuropathol 106:311–318. https://doi.org/10.1007/s00401-003-0732-z
Sanchez-Juan P, Bishop MT, Kovacs GG, Calero M, Aulchenko YS, Ladogana A, Boyd A, Lewis V et al (2015) A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt-Jakob disease risk. PLoS One 10:e0123654. https://doi.org/10.1371/journal.pone.0123654
Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, Kerrisk ME, Vortmeyer A et al (2013) Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron 79:887–902. https://doi.org/10.1016/j.neuron.2013.06.036
Beraldo FH, Arantes CP, Santos TG, Machado CF, Roffe M, Hajj GN, Lee KS, Magalhães AC et al (2011) Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin γ1 chain. FASEB J 25:265–279. https://doi.org/10.1096/fj.10-161653
Kimura T, Ishikawa K, Sakasegawa Y, Teruya K, Sata T, Schätzl H, Doh-ura K (2010) GABAA receptor subunit beta1 is involved in the formation of protease-resistant prion protein in prion-infected neuroblastoma cells. FEBS Lett 584:1193–1198. https://doi.org/10.1016/j.febslet.2010.02.029
Pocchiari M, Masullo C, Lust WD, Gibbs CJ Jr, Gajdusek DC (1985) Isonicotinic hydrazide causes seizures in scrapie-infected hamsters with shorter latency than in control animals: A possible GABAergic defect. Brain Res 326:117–1123
Abeliovich A, Gitler AD (2016) Defects in trafficking bridge Parkinson’s disease pathology and genetics. Nature 539:207–216. https://doi.org/10.1038/nature20414
Schreij AM, Fon EA, McPherson PS (2016) Endocytic membrane trafficking and neurodegenerative disease. Cell Mol Life Sci 73:1529–1545. https://doi.org/10.1007/s00018-015-2105-x
Campana V, Sarnataro D, Zurzolo C (2005) The highways and byways of prion protein trafficking. Trends Cell Biol 15:102–111. https://doi.org/10.1016/j.tcb.2004.12.002
Béranger F, Mangé A, Goud B, Lehmann S (2002) Stimulation of PrP(C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP (Sc) in prion-infected cells. J Biol Chem 277:38972–38977. https://doi.org/10.1074/jbc.M205110200
Borchelt DR, Taraboulos A, Prusiner SB (1992) Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem 267:16188–16199
Magalhães AC, Baron GS, Lee KS, Steele-Mortimer O, Dorward D, Prado MA, Caughey B (2005) Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells. J Neurosci 25:5207–5216. https://doi.org/10.1523/JNEUROSCI.0653-05.2005
Marijanovic Z, Caputo A, Campana V, Zurzolo C (2009) Identification of an intracellular site of prion conversion. PLoS Pathog 5:e1000426. https://doi.org/10.1371/journal.ppat.1000426
Aguzzi A, Rajendran L (2009) The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 64:783–790. https://doi.org/10.1016/j.neuron.2009.12.016
Frost B, Diamond MI (2010) Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 11:155–159. https://doi.org/10.1038/nrn2786
Liu S, Hossinger A, Göbbels S, Vorberg IM (2017) Prions on the run: How extracellular vesicles serve as delivery vehicles for self-templating protein aggregates. Prion 11:98–112. https://doi.org/10.1080/19336896.2017.1306162
Raposo G, Stoorvogel W (2013) Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 200:373–383. https://doi.org/10.1083/jcb.201211138
Hu YB, Dammer EB, Ren RJ, Wang G (2015) The endosomal-lysosomal system: From acidification and cargo sorting to neurodegeneration. Transl Neurodegener 4:18. https://doi.org/10.1186/s40035-015-0041-1
Boellaard JW, Kao M, Schlote W, Diringer H (1991) Neuronal autophagy in experimental scrapie. Acta Neuropathol 82:225–228
Kovács GG, Gelpi E, Ströbel T, Ricken G, Nyengaard JR, Bernheimer H, Budka H (2007) Involvement of the endosomal-lysosomal system correlates with regional pathology in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 66:628–636
Liberski PP, Sikorska B, Hauw JJ, Kopp N, Streichenberger N, Giraud P, Boellaard J, Budka H et al (2010) Ultrastructural characteristics (or evaluation) of Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies or prion diseases. Ultrastruct Pathol 34:351–361. https://doi.org/10.3109/01913123.2010.491175
Zafar S, Younas N, Correia S, Shafiq M, Tahir W, Schmitz M (2017) Strain-specific altered regulatory response of Rab7a and tau in Creutzfeldt-Jakob disease and Alzheimer’s disease. Mol Neurobiol 54:697–709. https://doi.org/10.1007/s12035-016-9694-8
Gouras GK (2013) Convergence of synapses, endosomes, and prions in the biology of neurodegenerative diseases. Int J Cell Biol 2013:141083. https://doi.org/10.1155/2013/14108
Guo BB, Bellingham SA, Hill AF (2016) Stimulating the release of exosomes increases the intercellular transfer of prions. J Biol Chem 291:5128–5137. https://doi.org/10.1074/jbc.M115.684258.
Hasegawa T, Sugeno N, Kikuchi A, Baba T, Aoki M (2017) Membrane trafficking illuminates a path to Parkinson’s disease. Tohoku J Exp Med 242:63–76. https://doi.org/10.1620/tjem.242.63
Aulić S, Masperone L, Narkiewicz J, Isopi E, Bistaffa E, Ambrosetti E, Pastore B, de Cecco E et al (2017) α-Synuclein amyloids hijack prion protein to gain cell entry, facilitate cell-to-cell spreading and block prion replication. Sci Rep 7:10050. https://doi.org/10.1038/s41598-017-10236-x
Fluharty BR, Biasini E, Stravalaci M, Sclip A, Diomede L, Balducci C, la Vitola P, Messa M et al (2013) An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo. J Biol Chem 288:7857–7866. https://doi.org/10.1074/jbc.M112.423954
Resenberger UK, Winklhofer KF, Tatzelt J (2011) Neuroprotective and neurotoxic signaling by the prion. Protein 305:101–119. https://doi.org/10.1007/128_2011_160.
Holmes BB, DeVos SL, Kfoury N, Li M, Jacks R, Yanamandra K et al (2013) Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci U S A 110:E3138–E3147. https://doi.org/10.1073/pnas.1301440110
Ballmer BA, Moos R, Liberali P, Pelkmans L, Hornemann S, Aguzzi A (2017) Modifiers of prion protein biogenesis and recycling identified by a highly parallel endocytosis kinetics assay. J Biol Chem 292:8356–8368. https://doi.org/10.1074/jbc.M116.773283
Nixon RA (2013) The role of autophagy in neurodegenerative disease. Nat Med 1:983–997. https://doi.org/10.1038/nm.3232
Schneider JL, Cuervo AM (2014) Autophagy and human disease: Emerging themes. Curr Opin Genet Dev 26:16–23. https://doi.org/10.1016/j.gde.2014.04.00.
Funding
Supported by EU Grant FP6, BNEII No LSHM-CT-2004-503039, the University of Bologna (Grant RFO) and the Gino Galletti Foundation.
Author information
Authors and Affiliations
Author notes
Hans Kretzschmar is deceased. This paper is dedicated to his memory.
- Hans Kretzschmar
Contributions
A.B.S. designed and supervised whole transcriptome analysis, performed and supervised mRNA studies, analyzed, interpreted the data, and wrote the manuscript. P.C. RNA designed and supervised extraction experiments and critically reviewed the manuscript. N.M. analyzed and interpreted the data and critically reviewed the manuscript. S.B. analyzed and interpreted the data and critically reviewed the manuscript. P.F.D. and R.R. designed and supervised the transcriptome analysis and critically reviewed the manuscript. T.A. selected and prepared the samples and critically reviewed the manuscript. H.K. participated in designing the project and provided some samples. S.C. designed and supervised the study and wrote the manuscript. P.P. collected and selected the brain samples, performed all histopathological analysis, supervised the overall study, and wrote the manuscript.
Corresponding authors
Ethics declarations
The protocol of the study was approved by the Local Ethics Committee.
Conflict of Interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Bartoletti-Stella, A., Corrado, P., Mometto, N. et al. Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease. Mol Neurobiol 56, 5009–5024 (2019). https://doi.org/10.1007/s12035-018-1421-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-018-1421-1